Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gerth van Wijk

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 12, 2016
sIgE Ana o 1, 2 and 3 accurately distinguish tolerant from allergic children sensitized to cashew nutsJ P M van der Valk, R Gerth van Wijk, Y Vergouwe, et al.
Allergy|October 3, 2009
National pholcodine consumption and prevalence of IgE-sensitization: a multicentre studyS G O Johansson, E Florvaag, H Oman, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|May 19, 2012
Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statementM A Calderon, R Gerth van Wijk, I Eichler, et al.
Allergy|November 23, 2016
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paperO Pfaar, K Bastl, U Berger, et al.
Allergy|April 26, 2014
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position PaperO Pfaar, P Demoly, R Gerth van Wijk, et al.
Allergy|May 24, 2014
EAACI position paper: irritant-induced asthmaO Vandenplas, M Wiszniewska, M Raulf, et al.
Allergy|May 22, 2010
Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paperF Braido, P J Bousquet, Z Brzoza, et al.
Allergy|August 30, 2017
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapyD Ryan, R Gerth van Wijk, E Angier, et al.
Allergy|January 31, 2018
EAACI guidelines on allergen immunotherapy: Executive statementA Muraro, G Roberts, S Halken, et al.
Allergy|April 19, 2011
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statementJean Bousquet, H J Schünemann, P J Bousquet, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 12, 2016
sIgE Ana o 1, 2 and 3 accurately distinguish tolerant from allergic children sensitized to cashew nutsJ P M van der Valk, R Gerth van Wijk, Y Vergouwe, et al.
Allergy|October 3, 2009
National pholcodine consumption and prevalence of IgE-sensitization: a multicentre studyS G O Johansson, E Florvaag, H Oman, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|May 19, 2012
Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statementM A Calderon, R Gerth van Wijk, I Eichler, et al.
Allergy|November 23, 2016
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paperO Pfaar, K Bastl, U Berger, et al.
Allergy|April 26, 2014
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position PaperO Pfaar, P Demoly, R Gerth van Wijk, et al.
Allergy|May 24, 2014
EAACI position paper: irritant-induced asthmaO Vandenplas, M Wiszniewska, M Raulf, et al.
Allergy|May 22, 2010
Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paperF Braido, P J Bousquet, Z Brzoza, et al.
Allergy|August 30, 2017
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapyD Ryan, R Gerth van Wijk, E Angier, et al.
Allergy|January 31, 2018
EAACI guidelines on allergen immunotherapy: Executive statementA Muraro, G Roberts, S Halken, et al.
Allergy|April 19, 2011
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statementJean Bousquet, H J Schünemann, P J Bousquet, et al.
Pageof 12